Extracorporeal Shock Wave Therapy in Peyronie’s Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study
ItalyPurpose: In this study, we aimed to determine the role of extracorporeal shockwave therapy (ESWT) in the management of Peyronie’s disease (PD). Materials and Methods: A total of 325 patients suffering from PD were enrolled in this single-arm clinical study. All patients were received ESWT using...
Main Authors: | Marina di Mauro, Giorgio Ivan Russo, Pier Andrea Della Camera, Fabrizio di Maida, Gianmartin Cito, Nicola Mondaini, Marco Capece, Marco Falcone, Francesco Sessa, Andrea Mari, Riccardo Campi, Carlotta Sabini, Sergio Serni, Mauro Gacci, Andrea Minervini, Marco Carini, Sebastiano Cimino, Girolamo Morelli, Andrea Cocci |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Sexual Medicine and Andrology
2019-09-01
|
Series: | The World Journal of Men's Health |
Subjects: |
Similar Items
-
Comparison of Intralesional Hyaluronic Acid vs . Verapamil for the Treatment of Acute Phase Peyronie’s Disease: A Prospective, Open-Label Non-Randomized Clinical Study
by: Andrea Cocci, et al.
Published: (2021-04-01) -
How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie’s Disease Receiving Collagenase Clostridium Histolyticum Therapy?
by: Andrea Cocci, et al.
Published: (2020-01-01) -
The Natural History of Peyronie’s Disease
by: Fabrizio Di Maida, et al.
Published: (2021-07-01) -
Application of Human Amniotic Membrane in Canine Penile Tunica Albuginea Defect: First Step toward an Innovating New Method for Treatment of Peyronie?s Disease
by: M. Salehipour, et al.
Published: (2014-06-01) -
The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie’s Disease in the United States
by: Andrew J. Sun, et al.
Published: (2019-05-01)